- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Krsnaa Diagnostics reported Q1 FY27 consolidated revenue of ₹235.5 Cr, a strong 22% YoY growth, with EBITDA increasing 12% to ₹58.8 Cr. However, Profit After Tax (PAT) declined 19% YoY to ₹16.6 Cr, mainly due to upfront fixed costs for new Rajasthan labs ahead of full utilization.
The retail segment is a standout, with revenue soaring 64% YoY to ₹19.3 Cr, now contributing 8% to total revenue, driven by a 75% rise in patient count and 47% in test volumes.
The company's strategy focuses on affordability, leveraging its Public-Private Partnership (PPP) infrastructure, and adopting AI-enabled diagnostics for efficiency. Recent developments include doubling NABH-accredited centres to 66. Krsnaa aims to expand its retail footprint with 1,000+ centres and scale home collection services, building a sustainable cash business.